Stock Earnings

Question 1

What are Kobayashi Pharmaceutical Co., Ltd.'s key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Kobayashi Pharmaceutical Co., Ltd. has a total asset of $275,329, Net profit of $3,656

Question 2

What are the key financial ratios for KBYPF?

Accepted Answer

Kobayashi Pharmaceutical Co., Ltd.'s Current ratio is 4.27, has a Net margin is 2.2, sales per share of $2,229.54.

Question 3

How is Kobayashi Pharmaceutical Co., Ltd.'s revenue broken down by segment or geography?

Accepted Answer

Kobayashi Pharmaceutical Co., Ltd. largest revenue segment is Domestic, at a revenue of 119,901,000,000 in the most earnings release.For geography, Japan is the primary market for Kobayashi Pharmaceutical Co., Ltd., at a revenue of 120,419,000,000.

Question 4

Is Kobayashi Pharmaceutical Co., Ltd. profitable?

Accepted Answer

yes, according to the latest financial statements, Kobayashi Pharmaceutical Co., Ltd. has a net profit of $3,656

Question 5

Does Kobayashi Pharmaceutical Co., Ltd. have any liabilities?

Accepted Answer

yes, Kobayashi Pharmaceutical Co., Ltd. has liability of 64,330

Question 6

How many outstanding shares for Kobayashi Pharmaceutical Co., Ltd.?

Accepted Answer

Kobayashi Pharmaceutical Co., Ltd. has a total outstanding shares of 74.33

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	165,742	165,742	165,600	173,455	166,258	155,252
Revenue Growth (YoY)	0%	0%	-5%	4%	7%	3%
Cost of Revenue	81,030	81,030	77,997	77,079	73,927	66,478
Gross Profit	84,712	84,712	87,603	96,376	92,331	88,774
Selling, General & Admin	69,788	55,390	48,793	58,387	54,669	52,790
Research & Development	--	9,122	9,109	9,004	8,327	7,522
Operating Expenses	69,789	69,789	62,743	70,596	65,662	62,709
Other Non Operating Income (Expenses)	823	823	884	777	821	898
Pretax Income	3,744	3,744	13,914	27,559	27,950	27,636
Income Tax Expense	83	83	3,842	7,221	7,927	7,920
Net Income	3,656	3,656	10,067	20,338	20,022	19,715
Net Income Growth	-64%	-64%	-51%	2%	2%	3%
Shares Outstanding (Diluted)	74.33	74.33	74.33	75.84	77.13	78.12
Shares Change (YoY)	0%	0%	-2%	-2%	-1%	0%
EPS (Diluted)	49.18	49.18	135.42	268.16	259.58	252.35
EPS Growth	-64%	-64%	-50%	3%	3%	3%
Free Cash Flow	11,579	11,579	-15,383	4,791	15,663	18,234
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	51.11%	51.11%	52.9%	55.56%	55.53%	57.18%
Operating Margin	9%	9%	15.01%	14.86%	16.04%	16.78%
Profit Margin	2.2%	2.2%	6.07%	11.72%	12.04%	12.69%
Free Cash Flow Margin	6.98%	6.98%	-9.28%	2.76%	9.42%	11.74%
EBITDA	23,668	20,199	29,700	28,984	29,335	28,460
EBITDA Margin	14.28%	12.18%	17.93%	16.7%	17.64%	18.33%
D&A For EBITDA	8,745	5,276	4,840	3,204	2,666	2,395
EBIT	14,923	14,923	24,860	25,780	26,669	26,065
EBIT Margin	9%	9%	15.01%	14.86%	16.04%	16.78%
Effective Tax Rate	2.21%	2.21%	27.61%	26.2%	28.36%	28.65%

Kobayashi Pharmaceutical Co., Ltd. (KBYPF) Financial

KBYPF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is KOBAYASHI PHARMACEUTICALS?

KBYPF Income

Follow-Up Questions